Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38181
CAS Number:
191217-81-9
Dihidrocloruro de pramipexol monohidrato
Purity:
≥ 98 % (HPLC)
Synonym(s):
( S )-2-Amino-4,5,6,7-tetrahidro-6-(propilamino)benzotiazoldihidrocloruro monohidrato, Dihidrocloruro de PPX monohidrato
Documents
$29.34 /100 mg
Tamaño
Request Bulk Quote
Información del producto

Pramipexole dihydrochloride monohydrate is a potent dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome. This compound acts by stimulating dopamine receptors in the brain, which helps to alleviate the symptoms associated with these neurological disorders. Its unique structure allows for effective penetration of the blood-brain barrier, making it a valuable therapeutic agent in managing motor control and reducing discomfort in patients.

In addition to its established medical applications, pramipexole dihydrochloride monohydrate is also being explored for potential uses in other neurological conditions, showcasing its versatility in research settings. Its favorable pharmacokinetic profile and relatively low side effect profile compared to other dopamine agonists make it a preferred choice among healthcare professionals. Researchers and industry professionals can leverage this compound for innovative studies aimed at understanding and treating various dopamine-related disorders, thus enhancing patient care and therapeutic outcomes.

Número CAS
191217-81-9
Fórmula molecular
C10H17N3S · 2HCl · H2O
Peso molecular
302.26
Número MDL
MFCD02183927
Punto de fusión
290 °C (descenso)
Rotación óptica
[a] D 20 = -65 a -71 ° (C=1 en MeOH)
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
191217-81-9
Fórmula molecular
C10H17N3S · 2HCl · H2O
Peso molecular
302.26
Número MDL
MFCD02183927
Punto de fusión
290 °C (descenso)
Rotación óptica
[a] D 20 = -65 a -71 ° (C=1 en MeOH)
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Pramipexole dihydrochloride monohydrate is widely utilized in research focused on:

  • Treatment of Parkinson's Disease: This compound is primarily used in the management of Parkinson's disease, helping to alleviate symptoms such as tremors and stiffness, thereby improving the quality of life for patients.
  • Restless Legs Syndrome (RLS): It is effective in treating RLS, providing relief from uncomfortable sensations in the legs, which can disrupt sleep and daily activities.
  • Neuroprotective Research: Researchers explore its neuroprotective properties, investigating its potential to protect neurons from damage, which could lead to advancements in treating neurodegenerative disorders.
  • Clinical Trials: The compound is frequently involved in clinical trials aimed at discovering new therapeutic uses, enhancing its role in pharmaceutical development.
  • Combination Therapies: It is often studied in combination with other medications to assess synergistic effects, potentially leading to more effective treatment regimens for various neurological conditions.

Citas